Amarin Corp Falls 7.7% (AMRN)

Shares of Amarin Corporation plc AMRN are trading down 7.7% at $7.69 per share during the Tuesday afternoon trading session. The day's range for shares of Amarin Corporation plc has been between $7.52 and $8.18 per share. The average price target of analysts who cover Amarin Corporation plc (AMRN) is $8.14 per share. Volume of 2.7 million shares is just above the daily average volume of 2.6 million shares. Amarin Corporation plc is a clinical-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. The company's lead product candidate is AMR101, the active ingredient in which is ethyl-EPA (ethyl icosapentate). Read more from Benzinga's Company news.